X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene
- PMID: 12727945
- DOI: 10.1210/jc.2002-021981
X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene
Abstract
Kallmann syndrome (KS) is characterized by the association of hypogonadotropic hypogonadism and anosmia. The gene underlying the X chromosome-linked form of the disease, KAL-1, consists of 14 coding exons. It encodes a glycoprotein, anosmin-1, which is involved in the embryonic migration of GnRH-synthesizing neurons and the differentiation of the olfactory bulbs. We describe herein the clinical heterogeneity in three affected brothers who carry a large deletion (exons 3-13) in KAL-1. All three had a history of hypogonadotropic hypogonadism with delayed puberty. Although brain magnetic resonance imaging showed hypoplastic olfactory bulbs in the three siblings, variable degrees of anosmia/hyposmia were shown by olfactometry. In addition, these brothers had different phenotypic anomalies, i.e. unilateral renal aplasia (siblings B and C), high-arched palate (sibling A), brachymetacarpia (sibling A), mirror movements (siblings A and B), and abnormal eye movements (sibling C). Last but not least, sibling A suffered from a severe congenital hearing impairment, a feature that had been reported in KS but had not yet been ascribed unambiguously to the X-linked form of the disease. The variable phenotype, both qualitatively and quantitatively, in this family further emphasizes the role of putative modifier genes, and/or epigenetic factors, in the expressivity of the X-linked KS.
Similar articles
-
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.Clin Endocrinol (Oxf). 2001 Aug;55(2):163-74. doi: 10.1046/j.1365-2265.2001.01277.x. Clin Endocrinol (Oxf). 2001. PMID: 11531922
-
A novel nonsense mutation of the KAL gene in two brothers with Kallmann syndrome.Horm Res. 2000;53(4):207-12. doi: 10.1159/000023568. Horm Res. 2000. PMID: 11044805
-
The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.J Clin Endocrinol Metab. 2001 Apr;86(4):1532-8. doi: 10.1210/jcem.86.4.7420. J Clin Endocrinol Metab. 2001. PMID: 11297579
-
A molecular approach to the pathophysiology of the X chromosome-linked Kallmann's syndrome.Baillieres Clin Endocrinol Metab. 1995 Jul;9(3):489-507. doi: 10.1016/s0950-351x(95)80553-2. Baillieres Clin Endocrinol Metab. 1995. PMID: 7575329 Review.
-
Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.Nat Clin Pract Endocrinol Metab. 2006 Mar;2(3):160-71. doi: 10.1038/ncpendmet0119. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932275 Review.
Cited by
-
Adult-onset idiopathic hypogonadotropic hypogonadism: possible aetiology, clinical manifestations and management.Asian J Androl. 2010 Jul;12(4):611-4. doi: 10.1038/aja.2010.34. Epub 2010 Jun 7. Asian J Androl. 2010. PMID: 20531282 Free PMC article. No abstract available.
-
Clinical and inheritance profiles of Kallmann syndrome in Jordan.Reprod Health. 2004 Oct 24;1(1):5. doi: 10.1186/1742-4755-1-5. Reprod Health. 2004. PMID: 15500697 Free PMC article.
-
Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications.J Clin Endocrinol Metab. 2012 Jan;97(1):E136-44. doi: 10.1210/jc.2011-2041. Epub 2011 Nov 9. J Clin Endocrinol Metab. 2012. PMID: 22072740 Free PMC article.
-
Kallmann syndrome.Eur J Hum Genet. 2009 Feb;17(2):139-46. doi: 10.1038/ejhg.2008.206. Epub 2008 Nov 5. Eur J Hum Genet. 2009. PMID: 18985070 Free PMC article.
-
Kallmann syndrome: fibroblast growth factor signaling insufficiency?J Mol Med (Berl). 2004 Nov;82(11):725-34. doi: 10.1007/s00109-004-0571-y. Epub 2004 Sep 8. J Mol Med (Berl). 2004. PMID: 15365636 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
